Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Statins, Cholesterol and Cognitive Decline in Alzheimer's

NCT06635252 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT06635252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06635252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Statins, Cholesterol and Cognitive Decline in Alzheimer's
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Completed
Start date
January 1, 2025
Completion date
March 1, 2025
Enrollment
2,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer dementia, statins